lanosterol

lanosterol is a lipid of Sterol Lipids (ST) class. Lanosterol is associated with abnormalities such as Infection, Atherosclerosis, Myocardial Infarction, Chagas Disease and Fatty Liver. The involved functions are known as Signal, Cytokinesis, physiological aspects, Stereochemistry and ergosterol biosynthetic process. Lanosterol often locates in Body tissue, Membrane, Plasma membrane, Tissue membrane and Cytoskeletal Filaments. The associated genes with lanosterol are Retinoic Acid Response Element, P4HTM gene, CYP51A1 gene, HM13 gene and SC4MOL gene. The related lipids are pneumocysterol, Sterols, lanosteryl acetate, ebericol and cycloartenol. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of lanosterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with lanosterol?

lanosterol is suspected in Atherosclerosis, Chagas Disease, vaginalis, hypercholesterolemia, Obesity, Infection and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with lanosterol

MeSH term MeSH ID Detail
Xanthomatosis D014973 17 associated lipids
Leukemia, Hairy Cell D007943 5 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Abetalipoproteinemia D000012 7 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with lanosterol

Lipid pathways are not clear in current pathway databases. We organized associated pathways with lanosterol through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with lanosterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with lanosterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with lanosterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with lanosterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with lanosterol?

Knock-out

Knock-out are used in the study 'Dual biosynthetic pathways to phytosterol via cycloartenol and lanosterol in Arabidopsis.' (Ohyama K et al., 2009), Knock-out are used in the study 'Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B.' (Warrilow AG et al., 2010) and Knock-out are used in the study 'Potential biological functions of cytochrome P450 reductase-dependent enzymes in small intestine: novel link to expression of major histocompatibility complex class II genes.' (D'Agostino J et al., 2012).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with lanosterol

Download all related citations
Per page 10 20 50 100 | Total 1125
Authors Title Published Journal PubMed Link
Alvarez-Vasquez F et al. Mathematical modeling and validation of the ergosterol pathway in Saccharomyces cerevisiae. 2011 PLoS ONE pmid:22194828
Keber R et al. Mouse knockout of the cholesterogenic cytochrome P450 lanosterol 14alpha-demethylase (Cyp51) resembles Antley-Bixler syndrome. 2011 J. Biol. Chem. pmid:21705796
Sangshetti JN et al. Synthesis, antifungal activity, and docking study of some new 1,2,4-triazole analogs. 2011 Chem Biol Drug Des pmid:21752200
Spitzer M et al. Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole. 2011 Mol. Syst. Biol. pmid:21694716
Alvarez-Rueda N et al. Amino acid substitutions at the major insertion loop of Candida albicans sterol 14alpha-demethylase are involved in fluconazole resistance. 2011 PLoS ONE pmid:21698128
Chauvigné F et al. Mono-(2-ethylhexyl) phthalate directly alters the expression of Leydig cell genes and CYP17 lyase activity in cultured rat fetal testis. 2011 PLoS ONE pmid:22087261
Elias PM et al. Pathogenesis of the cutaneous phenotype in inherited disorders of cholesterol metabolism: Therapeutic implications for topical treatment of these disorders. 2011 Dermatoendocrinol pmid:21695019
Liu Y et al. Sensitive and selective liquid chromatography-tandem mass spectrometry method for the determination of five ganoderic acids in Ganoderma lucidum and its related species. 2011 J Pharm Biomed Anal pmid:21130592
Zhang XQ et al. Triterpenoids with neurotrophic activity from Ganoderma lucidum. 2011 Nat. Prod. Res. pmid:21671206
Park HG et al. Heterologous expression and characterization of the sterol 14α-demethylase CYP51F1 from Candida albicans. 2011 Arch. Biochem. Biophys. pmid:21315684
Ito R et al. Triterpene cyclases from Oryza sativa L.: cycloartenol, parkeol and achilleol B synthases. 2011 Org. Lett. pmid:21526825
Tripodi KE et al. Role of heme and heme-proteins in trypanosomatid essential metabolic pathways. 2011 Enzyme Res pmid:21603276
Lou HY et al. Hepatic failure related to itraconazole use successfully treated by corticosteroids. 2011 Hepat Mon pmid:22224084
Semighini CP et al. Deletion of Cryptococcus neoformans AIF ortholog promotes chromosome aneuploidy and fluconazole-resistance in a metacaspase-independent manner. 2011 PLoS Pathog. pmid:22114551
Mullins JG et al. Molecular modelling of the emergence of azole resistance in Mycosphaerella graminicola. 2011 PLoS ONE pmid:21738598
Lat A and Thompson GR Update on the optimal use of voriconazole for invasive fungal infections. 2011 Infect Drug Resist pmid:21694908
Singh A and Prasad R Comparative lipidomics of azole sensitive and resistant clinical isolates of Candida albicans reveals unexpected diversity in molecular lipid imprints. 2011 PLoS ONE pmid:21559392
Vargas FA et al. Expanding a dynamic flux balance model of yeast fermentation to genome-scale. 2011 BMC Syst Biol pmid:21595919
Zhao Z et al. Cytosolic NADPH balancing in Penicillium chrysogenum cultivated on mixtures of glucose and ethanol. 2011 Appl. Microbiol. Biotechnol. pmid:20809073
Chen NH et al. Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression. 2010 Jan-Feb Pharmacol Rep pmid:20360625
Neil HA et al. Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial. 2010 Atherosclerosis pmid:21036355
Martinez-Seara H et al. Cholesterol induces specific spatial and orientational order in cholesterol/phospholipid membranes. 2010 PLoS ONE pmid:20567600
Zhang YQ et al. Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs. 2010 PLoS Pathog. pmid:20532216
Rani S et al. Phytochemical investigation of the seeds of Althea officinalis L. 2010 Nat. Prod. Res. pmid:20803381
Ren A et al. Methyl jasmonate induces ganoderic acid biosynthesis in the basidiomycetous fungus Ganoderma lucidum. 2010 Bioresour. Technol. pmid:20395130
Taramino S et al. Interactions of oxidosqualene cyclase (Erg7p) with 3-keto reductase (Erg27p) and other enzymes of sterol biosynthesis in yeast. 2010 Biochim. Biophys. Acta pmid:19879375
Chandrasekar SB et al. Phytopharmacology of Ficus religiosa. 2010 Pharmacogn Rev pmid:22228961
Mantzouridou F and Tsimidou MZ Observations on squalene accumulation in Saccharomyces cerevisiae due to the manipulation of HMG2 and ERG6. 2010 FEMS Yeast Res. pmid:20550581
Yadav VR et al. Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer. 2010 Toxins (Basel) pmid:22069560
Andreyev AY et al. Subcellular organelle lipidomics in TLR-4-activated macrophages. 2010 J. Lipid Res. pmid:20574076
Cicek SS et al. Bioactivity-guided isolation of GABA(A) receptor modulating constituents from the rhizomes of Actaea racemosa. 2010 J. Nat. Prod. pmid:21082802
Taramino S et al. Divergent interactions involving the oxidosqualene cyclase and the steroid-3-ketoreductase in the sterol biosynthetic pathway of mammals and yeasts. 2010 Biochim. Biophys. Acta pmid:20659585
Chung MJ et al. Anticancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells. 2010 Nutr Res Pract pmid:20607061
Zhu J et al. Effects of FoxO4 overexpression on cholesterol biosynthesis, triacylglycerol accumulation, and glucose uptake. 2010 J. Lipid Res. pmid:20037138
Zhu LW and Tang YJ Significance of protein elicitor isolated from Tuber melanosporum on the production of ganoderic acid and Ganoderma polysaccharides during the fermentation of Ganoderma lucidum. 2010 Bioprocess Biosyst Eng pmid:20369259
Sundar S and Chakravarty J Liposomal amphotericin B and leishmaniasis: dose and response. 2010 J Glob Infect Dis pmid:20606972
Yang XW et al. Abiesatrines A-J: anti-inflammatory and antitumor triterpenoids from Abies georgei Orr. 2010 Org. Biomol. Chem. pmid:20372737
Guan W et al. Antagonistic changes in sensitivity to antifungal drugs by mutations of an important ABC transporter gene in a fungal pathogen. 2010 PLoS ONE pmid:20593017
Domitrovic T et al. Structural and functional study of YER067W, a new protein involved in yeast metabolism control and drug resistance. 2010 PLoS ONE pmid:20567505
Owens CM et al. Chemical combinations elucidate pathway interactions and regulation relevant to Hepatitis C replication. 2010 Mol. Syst. Biol. pmid:20531405
Fatmawati S et al. Inhibition of aldose reductase in vitro by constituents of Ganoderma lucidum. 2010 Planta Med. pmid:20379959
Adams M et al. Antiplasmodial lanostanes from the Ganoderma lucidum mushroom. 2010 J. Nat. Prod. pmid:20384295
Zhang WX et al. Impact of oxygen level in gaseous phase on gene transcription and ganoderic acid biosynthesis in liquid static cultures of Ganoderma lucidum. 2010 Bioprocess Biosyst Eng pmid:19809834
Musaji N Antifungal drug resistance: not all azoles are equal. 2010 Expert Rev Anti Infect Ther pmid:20455680
Ianas V et al. Role of posaconazole in the treatment of oropharyngeal candidiasis. 2010 Infect Drug Resist pmid:21694893
Sharma A et al. Amelioration of lead-induced hepatotoxicity by Allium sativum extracts in Swiss albino mice. 2010 Libyan J Med pmid:21483544
Bennassar A and Grimalt R Management of tinea capitis in childhood. 2010 Clin Cosmet Investig Dermatol pmid:21437064
Modica S et al. Deciphering the nuclear bile acid receptor FXR paradigm. 2010 Nucl Recept Signal pmid:21383957
Pérez-Castrillón JL et al. Vitamin d levels and lipid response to atorvastatin. 2010 Int J Endocrinol pmid:20016682
Joffrion TM et al. Functional characterization and localization of Pneumocystis carinii lanosterol synthase. 2010 Eukaryotic Cell pmid:19897737